Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Gains from Sales and Divestitures (2022 - 2025)

Roivant Sciences' Gains from Sales and Divestitures history spans 4 years, with the latest figure at $297795.0 for Q2 2025.

  • For Q2 2025, Gains from Sales and Divestitures rose 2.35% year-over-year to $297795.0; the TTM value through Jun 2025 reached $297795.0, up 2.35%, while the annual FY2025 figure was $6.1 million, 242.71% up from the prior year.
  • Gains from Sales and Divestitures reached $297795.0 in Q2 2025 per ROIV's latest filing, down from $6.1 million in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $6.9 million in Q1 2023 to a low of $290968.0 in Q2 2024.
  • Average Gains from Sales and Divestitures over 4 years is $1.9 million, with a median of $918622.0 recorded in 2023.
  • Peak YoY movement for Gains from Sales and Divestitures: plummeted 87.74% in 2024, then skyrocketed 242.71% in 2025.
  • A 4-year view of Gains from Sales and Divestitures shows it stood at $2.3 million in 2022, then crashed by 58.37% to $955782.0 in 2023, then decreased by 7.78% to $881462.0 in 2024, then crashed by 66.22% to $297795.0 in 2025.
  • Per Business Quant, the three most recent readings for ROIV's Gains from Sales and Divestitures are $297795.0 (Q2 2025), $6.1 million (Q1 2025), and $881462.0 (Q4 2024).